Founuo Pharmaceutical: It is planned to sprint to the GEM IPO and is expected to raise 457 million yuan, and the revenue will come from the sales of compound polymyxin B ointment preparations


2022-09-26: [Chinese Article Link] On 23 September, Zhejiang Funo Pharmaceuticals Co. Ltd. submitted a statement (statement) on the first public offer of shares and their listing on the business board, pursuant to which the company intends to enter the market in a deep-seated IPO. The company's current total proposed public offer of stock


Note: This is a machine translated version of the Chinese news media article. A mature and nuanced reading is suggested.


What China Reads


Founuo Pharmaceutical: It is planned to sprint to the GEM IPO and is expected to raise 457 million yuan, and the revenue will come from the sales of compound polymyxin B ointment preparations


2022-09-26: [Article Link] On 23 September, Zhejiang Funo Pharmaceuticals Co. Ltd. submitted a statement (statement) on the first public offer of shares and their listing on the business board, pursuant to which the company intends to enter the market in a deep-seated IPO. The company's current total proposed public offer of stock

Note: This is a translated version of the Chinese news media article. A mature and nuanced reading is suggested.